[1] |
Yuan H, Zhang X, Zheng W, et al. Minocycline attenuates kidney injury in a rat modelof streptozotocin induced diabetic nephropathy[J]. Biol Pharm Bull, 2016, 39:1231-1237.
|
[2] |
田平平, 刘忠强, 孔静, 等. DNA甲基转移酶及分泌型卷曲相关蛋白1在糖尿病肾脏疾病大鼠肾组织中的表达研究[J].中国糖尿病杂志, 2018, 26:594-598.
|
[3] |
Calle P, Hotter G. Macrophage phenotype and fibrosis in diabetic nephropathy[J]. Int J Mol Sci, 2020, 21:1-14.
|
[4] |
孔静, 田平平, 李圆圆, 等. Wnt4及其抑制因子在糖尿病肾病大鼠肾组织中的表达[J]. 基础医学与临床, 2018, 38:194-199.
|
[5] |
Kadian LK, Yadav R, Nanda S, et al. High-risk HPV infection modulates the promoter hypermethylation of APC, SFRP1, and PTEN in cervical cancer patients of North India[J]. Mol Biol Rep, 2020, 47:9725-9732.
|
[6] |
王礼贤, 李琰, 康山. DNA甲基化转移酶DNMTs和甲基化结合蛋白MBDs在卵巢子宫内膜异位症中的表达及相关性研究[J]. 华中科技大学学报(医学版), 2020, 49:312-317.
|
[7] |
Giri AK, Aittokallio T. DNMT inhibitors increase methylation in the cancer genome[J]. Front Pharmacol, 2019, 10:1-11.
|
[8] |
Li Y, Ren D, Shen Y, et al. Altered DNA methylation of TRIM13 in diabetic nephropathy suppresses mesangial collagen synthesis by promoting ubiquitination of CHOP[J]. EBioMedicine, 2020, 51:1-13.
|
[9] |
Shi M, Tian P, Liu Z, et al. MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by actⅣating Wnt/ signalling[J]. Biosci Rep, 2020, 40:1-13.
|
[10] |
李亚东, 张红霞, 张亚霞.肝癌的表观遗传学研究进展[J].生命的化学, 2021, 41:1763-1769.
|
[11] |
肖枭, 王艳林, 黄利鸣. DNA甲基转移酶与肿瘤关系的研究进展[J]. 生命科学, 2019, 31:87-92.
|
[12] |
Milena J,Ⅳana N, Dejan N, et al. Genetic and epigeno-mic modifiers of diabetic neuropathy[J]. Int J Mol Sci, 2021, 22:1-19.
|
[13] |
Dobre M, Salvi A, Pelisenco IA, et al. Crosstalk between DNA methylation and gene mutations in colorectal cancer[J]. Front Oncol, 2021, 11:1-8.
|
[14] |
Kubiliute R, Zalimas A, Bakavicius A, et al. Clinical significance of ADAMTS19, BMP7, SIM1, and SFRP1 promoter methylation in renal clear cell carcinoma[J]. Onco Targets Ther, 2021, 5:4979-4990.
|